Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Arch Cardiovasc Dis ; 117(8-9): 505-513, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38981841

RESUMO

BACKGROUND: Pacemaker implantation combined with atrioventricular node ablation (AVNA) is a well-established strategy for uncontrolled atrial arrhythmias. Limited data are available regarding His bundle pacing (HBP) and left bundle branch area pacing (LBBAP) in this setting. AIM: To compare the outcomes of HBP and LBBAP in patients undergoing pacemaker implantation combined with AVN in routine clinical practice. METHODS: We prospectively included all patients who underwent AVNA after successful conduction system pacing (CSP) in two hospitals between September 2017 and May 2023. The primary outcome was the 1-year composite of first episode of heart failure hospitalization, symptomatic atrioventricular node reconduction requiring a second AVNA procedure, lead revision or death from any cause. RESULTS: A total of 164 patients underwent AVNA following successful CSP (68 HBP and 96 LBBAP). Mean pacemaker implantation and AVNA procedure times were shorter in the LBBAP group than the HBP group (46±18 vs 59±23min; P<0.001 and 31±12 vs 43±22min, respectively; P<0.001). Complete atrioventricular block was more frequently obtained in the LBBAP group (88/96 patients [92%] vs 54/68 patients [79%]; P=0.04). One-year freedom from the composite outcome was more frequent in the LBBAP group (89.7% vs 72.9%; hazard ratio 0.32, 95% confidence interval 0.14-0.72; P=0.01). The strategy was similarly effective in both groups with a significant improvement in NYHA class and left ventricular ejection fraction. A secondary pacing threshold elevation >1V occurred only in the HBP group (11%). CONCLUSION: In this prospective, comparative study, LBBAP provided better 1-year outcomes than HBP.


Assuntos
Nó Atrioventricular , Fascículo Atrioventricular , Estimulação Cardíaca Artificial , Humanos , Estudos Prospectivos , Masculino , Feminino , Fascículo Atrioventricular/fisiopatologia , Idoso , Nó Atrioventricular/fisiopatologia , Nó Atrioventricular/cirurgia , Resultado do Tratamento , Fatores de Tempo , Pessoa de Meia-Idade , Ablação por Cateter/efeitos adversos , Frequência Cardíaca , Fatores de Risco , Bloqueio Atrioventricular/terapia , Bloqueio Atrioventricular/fisiopatologia , Bloqueio Atrioventricular/diagnóstico , Idoso de 80 Anos ou mais , Insuficiência Cardíaca/fisiopatologia , Insuficiência Cardíaca/terapia , Insuficiência Cardíaca/diagnóstico , Insuficiência Cardíaca/mortalidade , Fibrilação Atrial/fisiopatologia , Fibrilação Atrial/diagnóstico , Fibrilação Atrial/terapia , Fibrilação Atrial/cirurgia , Potenciais de Ação
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa